Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Epithelial ovarian cancer (OC), including fallopian tube and primary peritoneal cancer, is the deadliest gynecologic malignant neoplasm with a 5-year relative survival of approximately 50%. This study will evaluate the concordance in folate receptor alpha (FRa) immunohistochemistry (IHC) in adult female participants with ovarian cancer. Archived tissue biopsies will be tested for FRa and data from approximately 1,000 participants will be collected. This is a retrospective study and testing will be performed prospectively on archived samples. Participants' charts will be reviewed. No drug will be administered as a part of this study. The duration of the study will be approximately 1 Year. There is no additional burden for participants in this trial.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Próbki pobrane podczas operacji lub biopsji z rakiem jajnika w zaawansowanym stadium, które nadają się do analizy.
- •Próbki nie starsze niż 5 lat, aby zapewnić ich dobrą jakość.
- •Próbki zawierające co najmniej 100 żywych komórek nowotworowych.
✗ Disqualifies
- •Próbki, których jest za mało lub są złej jakości (starsze niż 5 lat lub mają mniej niż 100 żywych komórek nowotworowych).
- •Tkanki pobrane po leczeniu lekiem ukierunkowanym na FRa.
- •Próbki pobrane metodą biopsji cienkoigłowej lub pobrane z płynów (np. z jamy brzusznej).
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 31, 2026
- Sex
- Female only
Locations (5)
Instituto Alexander Fleming /ID# 281479
Ciudad Autonoma de Buenos Aire, Argentina
Biomakers /ID# 280318
Buenos Aires, Argentina
Hospital Italiano de Buenos Aires /ID# 280315
Buenos Aires, Argentina
A.C. Camargo Cancer Center - Rua Professor Antonio Prudente /ID# 280407
São Paulo, Brazil
Fundacion Para La Investigacion Clinica Y Molecular Aplicada Del Cancer - Ficmac /ID# 282327
Bogotá, Colombia
Trial contact
Rebekah Taylor
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.